From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. STDs>
  4. Archives

STDs: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 251-275 of 509 are shown

AIDS-Related Cancers in Patients Who Interrupt HIV Therapy

The risk for AIDS-defining malignancies is greater among HIV-infected patients who interrupt ART than among those who receive continuous treatment.

HIV-1 Vaccine Candidate Ineffective

The vaccine used in the international STEP trial failed to prevent HIV-1 infection and also did not reduce viral load in those who became infected.

Failed Sexual Risk-Reduction Strategies Among MSM

Many MSM who acquired HIV infection through unprotected anal intercourse may have done so despite engaging in risk-reduction strategies.

New HIV Diagnoses Rising Among Young MSM in NYC

During the past 6 years, New York City health officials have documented a 33% increase in the number of HIV infections diagnosed among men younger . . .

HIV Encephalopathy in the Era of Potent Combination ART

Neurocognitive impairment, present in about one quarter of HIV-infected patients, improves in some but not all individuals after initiation of ART.

The Diaphragm as HIV Barrier

Diaphragms did not provide more protection than condoms against HIV transmission.

Sexual Abstinence Programs Don’t Prevent Risks from Sexual Contact

Abstinence-only programs were no more effective than other interventions, including no intervention.

Whole-Genome Study Reveals Clues for Improving Host Control of HIV

Of three loci found to explain 14% of the variance in HIV load, one is a potential target for vaccine development.

Acyclovir to Prevent HIV Infection?

In a Tanzanian trial described at the 4th IAS Conference, acyclovir had no effect on the incidence of HIV acquisition among women with HSV infection; however, adherence was quite poor.

Disappointing Data from Anti-HIV Microbicide Trials

The 2007 IAS Conference provided new details about the two cellulose-sulfate trials that were halted earlier this year.

HPV Vaccine Not Effective Therapeutically

A randomized clinical trial has shown that a bivalent HPV vaccine does not affect the clearance of preexisting infection.

Successful HIV Treatment Should Restore CD4-Cell Counts to Normal

Even with very low pretreatment counts, normalization seems the rule.

AIDS and Death Despite High CD4-Cell Counts

AIDS-related events and deaths occur even in HIV-infected patients with high CD4-cell counts; whether this means treatment should be started earlier is not certain.

Benefits of Condom Use at Sexual Debut Go Beyond Contraception

Several years after sexual debut, early condom users had lower STI rates than did nonusers.

False-Negative Rapid-Test Results in Early HIV Infection

Seattle investigators caution that rapid HIV tests might miss the early stages of infection, when patients are theoretically most infectious.

Is HPV Vaccine Therapeutic in Women with Preexisting Infection?

The vaccine showed no evidence of clearing oncogenic HPV subtypes in infected women.

HPV Vaccine Is Prophylactic, Not Therapeutic

HPV vaccine does not affect clearance of preexisting infection.

Gonorrhea and Chlamydia Prevalence

The high prevalence of chlamydia and gonorrhea in certain populations should inform screening and treatment strategies in the U.S.

Maraviroc

The first CCR5 antagonist to receive approval for treatment of HIV infection

FDA Approval: Maraviroc

The CCR5 antagonist maraviroc is an important new option for treatment-experienced patients — as long as they harbor CCR5-tropic virus.

Diaphragm and Gel: No Added Protection Against HIV

HIV-acquisition rates were similar between women randomized to use a diaphragm and lubricant gel together with condoms and women randomized to use only condoms.

Etravirine: A Second-Generation NNRTI

Etravirine shows promise for treatment of resistant HIV infection.

Disappointing Results from a Trial of Diaphragm Use for HIV Prevention

Rates of HIV acquisition were similar among women who received condoms plus diaphragms and those who received condoms only.

Cancers in HIV-Infected People and Transplant Recipients

Risk for a wide range of cancers, especially infection-related cancers, is increased in these populations.

Reasons for Nonadherence to ART

Black race, Hispanic ethnicity, age <40, alcohol or crack use during the previous year, homelessness, complex antiretroviral regimens, and depression were independently associated with nonadherence.

Items 251-275 of 509 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.